A biomimetic pancreatic cancer on-chip reveals endothelial ablation via ALK7 signaling
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive, lethal malignancy that invades adjacent vasculatures and spreads to distant sites before clinical detection. Although invasion into the peripancreatic vasculature is one of the hallmarks of PDAC, paradoxically, PDAC tumors also exhibit hypovascularity. How PDAC tumors become hypovascular is poorly understood. We describe an organotypic PDAC-on-a-chip culture model that emulates vascular invasion and tumor-blood vessel interactions to better understand PDAC-vascular interactions. The model features a 3D matrix containing juxtaposed PDAC and perfusable endothelial lumens. PDAC cells invaded through intervening matrix, into vessel lumen, and ablated the endothelial cells, leaving behind tumor-filled luminal structures. Endothelial ablation was also observed in in vivo PDAC models. We also identified the activin-ALK7 pathway as a mediator of endothelial ablation by PDAC. This tumor-on-a-chip model provides an important in vitro platform for investigating the process of PDAC-driven endothelial ablation and may provide a mechanism for tumor hypovascularity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In another study, a biomimetic 3D organotypic model unveiled a mechanism by which pancreatic cancer cells induce endothelial ablation, resulting in tumor-driven endothelial cell death and hypoxia (Nguyen et al., 2019).”
From Microphysiological systems as models for immunologically ‘cold’ tumors (2024) · cites this paper as Nguyen et al., 2019
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The study identified the activin-ALK7 signaling pathway as a key mediator of this endothelial ablation, suggesting a potential therapeutic strategy for pancreatic cancer by targeting this pathway.”
From Microphysiological systems as models for immunologically ‘cold’ tumors (2024) · cites this paper as Nguyen et al., 2019
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Several studies have used CoC models to study and understand the effects of these cues on intravasation (Figure 3D-G).”
From Cancer-on-chip models for metastasis: importance of the tumor microenvironment (2024) · cites this paper as [66]
In the citing paper
“Application of a chemotactic gradient of fetal bovine serum (FBS) around the blood vessel triggered the invasion of pancreatic cells, and the wrapping around the blood vessel prior to intravasation.”
From Cancer-on-chip models for metastasis: importance of the tumor microenvironment (2024) · cites this paper as [66]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer Metastasis: Building a Framework
Gupta, G. P., & Massagué, J. (2006) · Cell · doi:10.1016/j.cell.2006.11.001 · Cited by 4,247
Olive, K. P., Jacobetz, M. A., Davidson, C. J., Gopinathan, A., McIntyre, D., Honess, D., Madhu, B., Goldgraben, M. A., Caldwell, M. E., Allard, D., et al. (2009) · Science · doi:10.1126/science.1171362 · Cited by 3,170
EMT and Dissemination Precede Pancreatic Tumor Formation
Rhim, A. D., Mirek, E. T., Aiello, N. M., Maitra, A., Bailey, J. M., McAllister, F., Reichert, M., Beatty, G. L., Rustgi, A. K., Vonderheide, R. H., et al. (2012) · Cell · doi:10.1016/j.cell.2011.11.025 · Cited by 2,136
Self-citationInman, G. J., Nicolás, F. J., Callahan, J. F., Harling, J. D., Gaster, L. M., Reith, A. D., Laping, N. J., & Hill, C. S. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.1.65 · Cited by 1,634
Steeg, P. S. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.25 · Cited by 1,363 · cited 1×
“INTRODUCTION Although the diagnosis and treatment of cancer in its earliest stages has substantially improved outcomes in many tumors, survival rates in patients with tumors that have spread to distant sites remain dismal (1).”
Crossing the endothelial barrier during metastasis
Reymond, N., d'Água, B. B., & Ridley, A. J. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3628 · Cited by 922
In vitro microvessels for the study of angiogenesis and thrombosis
Zheng, Y., Chen, J., Craven, M., Choi, N. W., Totorica, S., Diaz-Santana, A., Kermani, P., Hempstead, B., Fischbach-Teschl, C., López, J. A., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1201240109 · Cited by 894
Three-dimensional microfluidic model for tumor cell intravasation and endothelial barrier function
Zervantonakis, I. K., Hughes-Alford, S. K., Charest, J. L., Condeelis, J. S., Gertler, F. B., & Kamm, R. D. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1210182109 · Cited by 872 · cited 1×
“…the interactions between tumor cells with twodimensional (2D) planar or 3D vessel like structures have demonstrated the value of juxtaposing tumor cells with the vascular compartment, especially in the context of investigating extravasation and intrava sation properties ( 14 , 15 , 19 – 21 ).”
Padua, D., & Massagué, J. (2009) · Cell Research · doi:10.1038/cr.2008.316 · Cited by 809
Human 3D vascularized organotypic microfluidic assays to study breast cancer cell extravasation
Jeon, J. S., Bersini, S., Gilardi, M., Dubini, G., Charest, J. L., Moretti, M., & Kamm, R. D. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1417115112 · Cited by 723
Cited by
Organ-on-a-Chip: A New Paradigm for Drug Development
Ma, C., Peng, Y., Li, H., & Chen, W. (2021) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2020.11.009 · Cited by 576
“An organotypic pancreatic cancer chip model (Figure 2a) was developed to investigate the interactions of pancreatic ductal adenocarcinoma (PDAC, a major exocrine pancreatic cancer) with the tumor vascular network, and the activin–ALK7 pathway identified to be the mechanism of PDAC hypovascularity, leading to poor drug…”
BackgroundOrgan-on-a-chip meets artificial intelligence in drug evaluation
Deng, S., Li, C., Cao, J., Cui, Z., Du, J., Fu, Z., Yang, H., & Chen, P. (2023) · Theranostics · doi:10.7150/thno.87266 · Cited by 260
“The authors identified the activin-ALK7 pathway as a mediator of endothelial ablation by pancreatic ductal adenocarcinoma, which results in the limitation of the delivery of chemotherapeutic drugs to the tumors at later stages, and they replicated their findings in mice [137].”
BackgroundMicrofluidics for Drug Development: From Synthesis to Evaluation
Liu, Y., Sun, L., Zhang, H., Shang, L., & Zhao, Y. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c01289 · Cited by 202
Bio-Inspired Nanomaterials for Micro/Nanodevices: A New Era in Biomedical Applications
Harun‐Ur‐Rashid, M., Jahan, I., Foyez, T., & Imran, A. B. (2023) · Micromachines · doi:10.3390/mi14091786 · Cited by 186
Recurrent Urinary Tract Infection: A Mystery in Search of Better Model Systems
Murray, B. O., Flores, C., Williams, C., Flusberg, D. A., Marr, E. E., Kwiatkowska, K. M., Charest, J. L., Isenberg, B. C., & Rohn, J. L. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.691210 · Cited by 183
Patient-derived pancreatic cancer-on-a-chip recapitulates the tumor microenvironment
Haque, M. R., Wessel, C. R., Leary, D. D., Wang, C., Bhushan, A., & Bishehsari, F. (2022) · Microsystems & Nanoengineering · doi:10.1038/s41378-022-00370-6 · Cited by 137
Tumor-on-chip modeling of organ-specific cancer and metastasis
Del Piccolo, N., Shirure, V. S., Bi, Y., Goedegebuure, S. P., Gholami, S., Hughes, C. C. W., Fields, R. C., & George, S. C. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.05.008 · Cited by 126
Blueprint for cancer research: Critical gaps and opportunities
Elmore, L. W., Greer, S. F., Daniels, E. C., Saxe, C. C., Melner, M. H., Krawiec, G. M., Cance, W. G., & Phelps, W. C. (2020) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21652 · Cited by 157
3D approaches to model the tumor microenvironment of pancreatic cancer
Tomás-Bort, E., Kieler, M., Sharma, S., Candido, J. B., & Loessner, D. (2020) · Theranostics · doi:10.7150/thno.42441 · Cited by 114
“Therefore, there is a demand for preclinical models that can accurately mimic the TME as seen in patients [24-29] (Table 1).”
BackgroundMethodTranslating complexity and heterogeneity of pancreatic tumor: 3D in vitro to in vivo models
Heinrich, M. A., Mostafa, A. M. R. H., Morton, J. P., Hawinkels, L. J. A. C., & Prakash, J. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.04.018 · Cited by 126
Organ-on-a-chip systems for vascular biology
Mandrycky, C., Howard, C. C., Rayner, S. G., Shin, Y. J., & Zheng, Y. Y. (2021) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2021.06.002 · Cited by 107
Manoukian, P., Bijlsma, M. F., & van Laarhoven, H. W. M. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.743907 · Cited by 102
In vitro modeling of solid tumor interactions with perfused blood vessels
Kwak, T. J., & Lee, E. (2020) · Scientific Reports · doi:10.1038/s41598-020-77180-1 · Cited by 96
Self-citationThe tumour microenvironment in pancreatic cancer — new clinical challenges, but more opportunities
Kung, H., Zheng, K., Zimmerman, J. W., & Zheng, L. (2025) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-025-01077-z · Cited by 100
Strelez, C., Chilakala, S., Ghaffarian, K., Lau, R., Spiller, E. R., Ung, N. M., Hixon, D., Yoon, A. Y., Sun, R., Lenz, H., et al. (2021) · iScience · doi:10.1016/j.isci.2021.102509 · Cited by 92
“Our data support published evidence that the tumor:blood vessel tissue:tissue interface is a critical modulator of cancer progression (Amos and Choi, 2021; Choi and Moon, 2018; Nguyen et al., 2019).”
Hynes, W. F., Pepona, M., Robertson, C., Alvarado, J. A., Dubbin, K., Triplett, M., Adorno, J. J., Randles, A. P., & Moya, M. L. (2020) · Science Advances · doi:10.1126/sciadv.abb3308 · Cited by 88
Engineered tissues and strategies to overcome challenges in drug development
Khalil, A. S., Jaenisch, R., & Mooney, D. J. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.09.012 · Cited by 89
“Specifically, themodel helped to show that adenocarcinomametastases relied on pancreatic ductal endothelial ablation that was dependent on the ALK7 pathway of TGF-β signaling and that broad-spectrum inhibitors of TGF -β signaling could limit this effect [235].”
Tumor-on-a-chip platform to interrogate the role of macrophages in tumor progression
Bi, Y., Shirure, V. S., Liu, R., Cunningham, C., Ding, L., Meacham, J. M., Goedegebuure, S. P., George, S. C., & Fields, R. C. (2020) · Integrative Biology · doi:10.1093/intbio/zyaa017 · Cited by 70
Hwang, D. G., Choi, Y., & Jang, J. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.685507 · Cited by 81
Tumor-on-a-chip models combined with mini-tissues or organoids for engineering tumor tissues
Hwangbo, H., Chae, S., Kim, W.-J., Jo, S., & Kim, G. (2023) · Theranostics · doi:10.7150/thno.90093 · Cited by 74
Huerta-López, C., & Alegre‐Cebollada, J. (2021) · Nanomaterials · doi:10.3390/nano11071656 · Cited by 70
“Some of the most striking tissue developments include microfabricated blood vessels to model vascular transport [208], and pancreatic ductal adenocarcinoma on-a-chip to study endothelial defects [209].”
BackgroundCancer-on-chip models for metastasis: importance of the tumor microenvironment
Jouybar, M., de Winde, C. M., Wolf, K., Friedl, P., Mebius, R. E., & den Toonder, J. M. J. (2024) · Trends in Biotechnology · doi:10.1016/j.tibtech.2023.10.001 · Cited by 66
“(F) The role of a chemotactic gradient on pancreatic cancer cell invasion and intravasation [66].”
BackgroundMethodThe Cancer Microenvironment: Mechanical Challenges of the Metastatic Cascade
Amos, S. E., & Choi, Y. S. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.625859 · Cited by 73
“In platforms that lack perfusion, metastatic cells still perturb the endothelium’s structural integrity to facilitate intravasation, findings that are supported in vivo (Nguyen et al., 2019).”
BackgroundOrgan-On-A-Chip: An Emerging Research Platform
Nithin, R., Aggarwal, A., Sravani, A. B., Mallya, P., & Lewis, S. A. (2023) · Organogenesis · doi:10.1080/15476278.2023.2278236 · Cited by 69
“33,34”
Hong, S., JUNG, D., Kiemen, A. L., Gaida, M. M., Yoshizawa, T., Braxton, A. M., Noë, M., Lionheart, G., Oshima, K., Thompson, E. D., et al. (2019) · Modern Pathology · doi:10.1038/s41379-019-0409-3 · Cited by 66
Saha, B., Mathur, T., Handley, K. F., Hu, W., Afshar-Kharghan, V., Sood, A. K., & Jain, A. (2020) · Blood Advances · doi:10.1182/bloodadvances.2020001632 · Cited by 63
“More recently, this method was deployed to reveal pathological interactions between pancreatic cancer cells and endothelial cells.(20) The integrative nexus of cancer, vascular biology, and hematology has not been modeled thus far.”
MethodRecent advances in microfluidic technology and applications for anti-cancer drug screening
Shi, Y., Cai, Y., Cao, Y., Hong, Z., & Chai, Y. (2020) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2020.116118 · Cited by 63
Henderson, A. R., Choi, H., & Lee, E. (2020) · Micromachines · doi:10.3390/mi11020147 · Cited by 64
Self-citationBridging the gap between tumor-on-chip and clinics: a systematic review of 15 years of studies
Bouquerel, C., Dubrova, A., Hofer, I., Phan, D. T. T., Bernheim, M., Ladaigue, S., Cavaniol, C., Maddalo, D., Cabel, L., Mechta-Grigoriou, F., et al. (2023) · Lab on a Chip · doi:10.1039/d3lc00531c · Cited by 58
Im, G., & Lin, R. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.1053491 · Cited by 63
“(Ci) Schematic of PDAC-on-a-chip.”
BackgroundInfluentialPoly(ethylene glycol)–Norbornene as a Photoclick Bioink for Digital Light Processing 3D Bioprinting
Kim, M. H., & Lin, C. (2023) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.2c20098 · Cited by 57
Human Organs‐on‐Chips: A Review of the State‐of‐the‐Art, Current Prospects, and Future Challenges
Zarrintaj, P., Saeb, M. R., Stadler, F. J., Yazdi, M. K., Nasirinezhad, M., Mohebbi, S., Seidi, F., Ganjali, M. R., & Mozafari, M. (2021) · Advanced Biology · doi:10.1002/adbi.202000526 · Cited by 56
Urbanczyk, M., Zbinden, A., & Schenke‐Layland, K. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114323 · Cited by 58
Cancer-on-chip: a 3D model for the study of the tumor microenvironment
Cauli, E., Polidoro, M. A., Marzorati, S., Bernardi, C., Rasponi, M., & Lleò, A. (2023) · Journal of Biological Engineering · doi:10.1186/s13036-023-00372-6 · Cited by 52
Cancer-on-a-chip for precision cancer medicine
Liu, L., Wang, H., Chen, R., Song, Y., Wei, W., Baek, D. S. H., Gillin, M., Kurabayashi, K., & Chen, W. (2025) · Lab on a Chip · doi:10.1039/d4lc01043d · Cited by 52
Kaemmerer, E., Loessner, D., & Avery, V. M. (2020) · Drug Discovery Today · doi:10.1016/j.drudis.2020.11.030 · Cited by 56
Developmental angiocrine diversification of endothelial cells for organotypic regeneration
Gómez-Salinero, J. M., Itkin, T., & Rafii, S. (2021) · Developmental Cell · doi:10.1016/j.devcel.2021.10.020 · Cited by 50
Engineering New Microvascular Networks On‐Chip: Ingredients, Assembly, and Best Practices
Tronolone, J. J., & Jain, A. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202007199 · Cited by 50
The Revolutionary Roads to Study Cell–Cell Interactions in 3D In Vitro Pancreatic Cancer Models
Cave, D. D., Rizzo, R., Sáinz, B., Gigli, G., del Mercato, L. L., & Lonardo, E. (2021) · Cancers · doi:10.3390/cancers13040930 · Cited by 50
Tien, J., & Dance, Y. W. (2020) · Advanced Healthcare Materials · doi:10.1002/adhm.202001028 · Cited by 49
In Vitro Modeling of the Tumor Microenvironment in Tumor Organoids
Devarasetty, M., Forsythe, S. D., Shelkey, E., & Söker, S. (2020) · Tissue Engineering and Regenerative Medicine · doi:10.1007/s13770-020-00258-4 · Cited by 51
3D Collagen-Nanocellulose Matrices Model the Tumour Microenvironment of Pancreatic Cancer
Curvello, R., Kast, V., Abuwarwar, M. H., Fletcher, A. L., Garnier, G., & Loessner, D. (2021) · Frontiers in Digital Health · doi:10.3389/fdgth.2021.704584 · Cited by 45
“Advances in tissue engineering technologies enabled scientists to deconstruct and mimic individual components of the TME, emulating the dynamics arising from the diverse extracellular and cellular elements (7, 8).”
BackgroundFunctional Drug Screening in the Era of Precision Medicine
Napoli, G. C., Figg, W. D., & Chau, C. H. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.912641 · Cited by 45
“In pancreatic cancer, microfluidic chips have been used to study metastasis (59) and humanized microfluidic devices have allowed for drug combination screening (60).”
MethodRapid multilayer microfabrication for modeling organotropic metastasis in breast cancer
Kwak, T. J., & Lee, E. (2020) · Biofabrication · doi:10.1088/1758-5090/abbd28 · Cited by 39
“Alternatively, a needle casting layer and amedia reservoir layer were fabricated as separate parts and assembled in the casting process [20, 21].”
MethodSelf-citationOrgan-Chip Models: Opportunities for Precision Medicine in Pancreatic Cancer
Haque, M. R., Rempert, T. H., Al-Hilal, T. A., Wang, C., Bhushan, A., & Bishehsari, F. (2021) · Cancers · doi:10.3390/cancers13174487 · Cited by 36
“In a biomimetic OOCs based model of PDAC, endothelial ablation was seen where PDAC cells invaded the matrix toward the endothelial lumen, wrapped around the blood vessel, spread along the length, and finally invaded the vessel and occupied the vessel lumen [66].”
BackgroundMethodResultInfluentialMulti-Organs-on-Chips for Testing Small-Molecule Drugs: Challenges and Perspectives
Çeçen, B., Karavasili, C., Nazir, M., Bhusal, A., Dogan, E., Shahriyari, F., Tamburacı, S., Büyüköz, M., Kozacı, L. D., & Miri, A. K. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13101657 · Cited by 42
On-chip modeling of tumor evolution: Advances, challenges and opportunities
Li, C., Holman, J. B., Shi, Z., Qiu, B., & Ding, W. (2023) · Materials Today Bio · doi:10.1016/j.mtbio.2023.100724 · Cited by 39
Soden, P. A., Henderson, A. R., & Lee, E. (2022) · Advanced Biology · doi:10.1002/adbi.202200027 · Cited by 40
Self-citationRecent advances in vascularized tumor-on-a-chip
Huang, C. B. X., & Tu, T.-Y. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1150332 · Cited by 34
“(36) investigated the interaction between a biomimetic pancreatic cancer duct and a blood vessel positioned 500 μm apart.”
BackgroundLencioni, G., Gregori, A., Toledo, B., Rebelo, R., Immordino, B., Amrutkar, M., Xavier, C. P. R., Kocijancic, A., Pandey, D. P., Perán, M., et al. (2024) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2024.09.002 · Cited by 35
Organ-on-a-Chip systems for new drugs development
Vargas, R., Medina, L., & Egurbide, A. (2021) · ADMET & DMPK · doi:10.5599/admet.942 · Cited by 35
Stem cell-based vascularization of microphysiological systems
Browne, S., Gill, E., Schultheiss, P. J., Goswami, I., & Healy, K. E. (2021) · Stem Cell Reports · doi:10.1016/j.stemcr.2021.03.015 · Cited by 34
Engineering strategies to capture the biological and biophysical tumor microenvironment in vitro
Tan, M. L., Lu, L., & Fischbach, C. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113852 · Cited by 32
Strategies for developing complex multi-component in vitro tumor models: Highlights in glioblastoma
DePalma, T. J., Sivakumar, H., & Skardal, A. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.114067 · Cited by 33
Wang, R., Zhang, C., Li, D., & Yao, Y. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.1057913 · Cited by 33
Hydrogel Models with Stiffness Gradients for Interrogating Pancreatic Cancer Cell Fate
Chang, C., & Lin, C. (2021) · Bioengineering · doi:10.3390/bioengineering8030037 · Cited by 31
“proposed that cancer cells could invade and remove the vascular endothelium, a process that they termed “endothelial ablation”, and could potentially account for the hypovascularity in PDAC [47].”
BackgroundIGFBP2 secretion by mammary adipocytes limits breast cancer invasion
Conway, J. R. W., Dinç, D. D., Follain, G., Paavolainen, O., Kaivola, J., Boström, P., Hartiala, P., Peuhu, E., & Ivaska, J. (2023) · Science Advances · doi:10.1126/sciadv.adg1840 · Cited by 29
“In contrast to our work, others have shown that HUVECs cultured in three-dimensional (3D) microfluidic channels under flow induce the invasion of adjacent pancreatic cancer cells ( 10 , 11 ).”
The Influence of Chronic Liver Diseases on Hepatic Vasculature: A Liver-on-a-chip Review
Özkan, A., Stolley, D. L., Cressman, E. N. K., McMillin, M., DeMorrow, S., Yankeelov, T. E., & Rylander, M. N. (2020) · Micromachines · doi:10.3390/mi11050487 · Cited by 31
Ilan, I. S., Yslas, A. R., Peng, Y., Lu, R., & Lee, E. (2023) · Cellular and Molecular Bioengineering · doi:10.1007/s12195-023-00780-0 · Cited by 28
Self-citationFungi, host immune response, and tumorigenesis
Elaskandrany, M., Patel, R., Patel, M. M., Miller, G., Saxena, D., & Saxena, A. D. (2021) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00025.2021 · Cited by 29
Conte, M., & Cauda, V. (2022) · Advanced Therapeutics · doi:10.1002/adtp.202200079 · Cited by 29
Morris, E. K., Daignault, S. M., Stehbens, S. J., Genovesi, L. A., & Lagendijk, A. K. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1101522 · Cited by 28
Advances in screening hyperthermic nanomedicines in 3D tumor models
Soeiro, J. F., Sousa, F. L., Monteiro, M. V., Gaspar, V. M., Silva, N. J. O., & Mano, J. F. (2024) · Nanoscale Horizons · doi:10.1039/d3nh00305a · Cited by 30
An engineered pancreatic cancer model with intra-tumoral heterogeneity of driver mutations
Moon, H., Özçelikkale, A., Yang, Y., Elzey, B. D., Konieczny, S. F., & Han, B. (2020) · Lab on a Chip · doi:10.1039/d0lc00707b · Cited by 29
3D Pancreatic Tissue Modeling in vitro: Advances and Prospects
Kim, M., Hwang, D. G., & Jang, J. (2020) · BioChip Journal · doi:10.1007/s13206-020-4108-4 · Cited by 27
Keeping It Organized: Multicompartment Constructs to Mimic Tissue Heterogeneity
Sanchez-Rubio, A., Jayawarna, V., Maxwell, E., Dalby, M. J., & Salmerón‐Sánchez, M. (2023) · Advanced Healthcare Materials · doi:10.1002/adhm.202202110 · Cited by 26
Bioengineering Approaches for the Pancreatic Tumor Organoids Research and Application
Song, T., Kong, B., Liu, R., Luo, Y., Wang, Y., & Zhao, Y. (2023) · Advanced Healthcare Materials · doi:10.1002/adhm.202300984 · Cited by 24
Recent advances in cancer-on-a-chip tissue models to dissect the tumour microenvironment
Seaman, K., Sun, Y., & You, L. (2023) · Med-X · doi:10.1007/s44258-023-00011-1 · Cited by 26
“Therefore, a model of a biomimetic PDAC ductal channel co-cultured beside an endothelialized and perfused lumen channel to observe PDAC-endothelial interactions was created [86].”
BackgroundMethodInfluentialVascularized tumor models for the evaluation of drug delivery systems: a paradigm shift
Lopez-Vince, E., Wilhelm, C., & Simón‐Yarza, T. (2024) · Drug Delivery and Translational Research · doi:10.1007/s13346-024-01580-3 · Cited by 26
How organ-on-a-chip is advancing cancer research and oncology - a cancer hallmarks’ perspective
Avula, L. R., & Grodzinski, P. A. (2024) · Frontiers in Lab on a Chip Technologies · doi:10.3389/frlct.2024.1487377 · Cited by 26
Lim, J., Fang, H., Bupphathong, S., Sung, P.-C., Yeh, C.-E., Huang, W. R., & Lin, C.-H. (2024) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.3c01978 · Cited by 25
Benjakul, N., Prakobphol, N., Tangshewinsirikul, C., Dulyaphat, W., Svasti, J., Charngkaew, K., & Kangsamaksin, T. (2022) · PLoS ONE · doi:10.1371/journal.pone.0279001 · Cited by 26
Rethinking the Roles of Cancer-Associated Fibroblasts in Pancreatic Cancer
Francescone, R., Crawford, H. C., & Costa, D. B. V. (2024) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2024.01.022 · Cited by 22
“26 29 “ Organ on a chip ” models, 30,31 which also factor fl uid pressure and shear forces, mimicking the high tumor interstitial pressure found in PDAC tumors, modulate signaling and cell interactions in a manner reminiscent of human tumors.”
BackgroundGeyer, M., & Queiroz, K. C. S. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.761807 · Cited by 23
Strategies to control cellular spatial organization in microphysiological systems
Truong, H. D., Ge, Z., Chng, E., Tran, Y.-V., Zhang, Y., & Lim, C. T. (2026) · Microsystems & Nanoengineering · doi:10.1038/s41378-025-01141-9 · Cited by 21
“For instance, to study the hypovascularity phenomenon in pancreatic ductal adenocarcinoma (PDAC), Nguyen et al. developed a PDAC-on-a-chip model in which both PDAC and endothelial channels were embedded in a 3D collagen matrix 248 .”
Engineering of biomaterials for tumor modeling
Choi, S. R., Yang, Y., Huang, K., Kong, H., Flick, M. J., & Han, B. (2020) · Materials Today Advances · doi:10.1016/j.mtadv.2020.100117 · Cited by 23
Pancreatic organoids as cancer avatars for true personalized medicine
Gout, J., Ekizce, M., Roger, É., & Kleger, A. (2025) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2025.115642 · Cited by 23
Mimicking blood and lymphatic vasculatures using microfluidic systems
Hall, E., Mendiola, K., Lightsey, N. K., & Hanjaya‐Putra, D. (2024) · Biomicrofluidics · doi:10.1063/5.0175154 · Cited by 20
Monteiro, M. V., Rocha, M., Carvalho, M. T., Freitas, I., Amaral, A. J. R., Sousa, F. L., Gaspar, V. M., & Mano, J. F. (2024) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.4c11188 · Cited by 20
Advances in bioengineering pancreatic tumor-stroma physiomimetic Biomodels
Monteiro, M. V., Ferreira, L. P., Rocha, M., Gaspar, V. M., & Mano, J. F. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121653 · Cited by 19
3D printed microfluidics for cell biological applications
Zhao, L., & Wang, X. (2022) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2022.116864 · Cited by 21
Nanomedicine and epigenetics: New alliances to increase the odds in pancreatic cancer survival
Urbanova, M., Cihova, M., Buociková, V., Slopovský, J., Dubovan, P., Pinďák, D., Tomáš, M., García‐Bermejo, L., Rodríguez-Garrote, M., Earl, J., et al. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115179 · Cited by 20
Vascular microphysiological systems (MPS): biologically relevant and potent models
Breuil, L., Kitada, A., Yadav, S., Zhou, H., Fujimoto, K., & Yokokawa, R. (2025) · Lab on a Chip · doi:10.1039/d5lc00014a · Cited by 19
Vaskovich‐Koubi, D., Buzhor, M. G., Krinsky, A., Roth, Y., Salomon, K., Kleiner, R., Sevostianov, R., Hasin, O., Khoury, R., & Satchi‐Fainaro, R. (2025) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2025.115670 · Cited by 19
Activin receptors in human cancer: Functions, mechanisms, and potential clinical applications
Du, R., Wen, L., Niu, M., Zhao, L., Guan, X., Jiao, Y., Zhang, C., & Liu, H. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116061 · Cited by 18
Kim, H., Cho, S., & Kim, H. N. (2025) · Macromolecular Bioscience · doi:10.1002/mabi.202500240 · Cited by 18
Microphysiological Systems for Cancer Immunotherapy Research and Development
Peng, Y., & Lee, E. (2023) · Advanced Biology · doi:10.1002/adbi.202300077 · Cited by 17
Self-citationSamantasinghar, A., Sunildutt, N., Ahmed, F., Memon, F. H., Kang, C.-U., & Choi, K. H. (2025) · ACS Omega · doi:10.1021/acsomega.4c11227 · Cited by 19
Dubrova, A., Cavaniol, C., de Walle, A. V., Mathieu, P., Fusilier, Z., Yaacoub, N., Lalatonne, Y., Descroix, S., & Wilhelm, C. (2025) · ACS Nano · doi:10.1021/acsnano.5c02099 · Cited by 17
Desmin and CD31 immunolabeling for detecting venous invasion of the pancreatobiliary tract cancers
Shin, J., Wood, L. D., Hruban, R. H., & Hong, S. (2020) · PLoS ONE · doi:10.1371/journal.pone.0242571 · Cited by 17
Heterocellular crosstalk and architecture of the pancreatic tumour microenvironment
Arnold, F., Vecchio, A. D., Hussain, Z., & Sherman, M. H. (2026) · Nature reviews. Cancer · doi:10.1038/s41568-025-00905-9 · Cited by 17
Building Blood Vessel Chips with Enhanced Physiological Relevance
Mu, X., Gerhard‐Herman, M. D., & Zhang, Y. S. (2023) · Advanced Materials Technologies · doi:10.1002/admt.202201778 · Cited by 16
A 3D Bio-Printed-Based Model for Pancreatic Ductal Adenocarcinoma
Godier, C., Baka, Z., Lamy, L., Gribova, V., Marchal, P., Lavall�e, P., Gaffet, É., Bezdetnaya, L., & Alem, H. (2024) · Diseases · doi:10.3390/diseases12090206 · Cited by 16
3D in vitro modeling of the exocrine pancreatic unit using tomographic volumetric bioprinting
Sgarminato, V., Madrid-Wolff, J. A., Boniface, A., Ciardelli, G., Tonda‐Turo, C., & Moser, C. (2024) · Biofabrication · doi:10.1088/1758-5090/ad6d8d · Cited by 15
“The understanding of pancreatic cancer raises interests among the scientific community, currently developing efficient PDAC in vitro models in order to detect the disease earlier and design effective therapies thus improving patients’ prognosis [22– 27].”
Jouybar, M., van der Kallen, S., Sahebali, S. S., Bouten, C. V. C., & den Toonder, J. M. J. (2025) · Advanced Materials Technologies · doi:10.1002/admt.202401994 · Cited by 16
Maschmeyer, I., & Kakava, S. (2020) · Advances in biochemical engineering, biotechnology · doi:10.1007/10_2020_135 · Cited by 16
Directing Cholangiocyte Morphogenesis in Natural Biomaterial Scaffolds
Smith, Q., Bays, J., Li, L., Shareef, H., Chen, C. S., & Bhatia, S. N. (2021) · Advanced Science · doi:10.1002/advs.202102698 · Cited by 16
“also supported in an engineered microfluidic platform that has been used previously as 96 an organ-on-chip model system([1,27,28]).”
BackgroundMethodSelf-citationBaka, Z., Stiefel, M., Figarol, A., Godier, C., Mallick, A., Joubert, O., Ashammakhi, N. A., Gaffet, É., & Alem, H. (2022) · Progress in Biomedical Engineering · doi:10.1088/2516-1091/ac8259 · Cited by 15
“For example, a recent work published in 2019 highlighted an important phenomenon called ‘endothelial ablation’ [108] using a microfluidic device.”
InfluentialNgo, H. T., Amartumur, S., Tran, V. T. A., Tran, M., Diep, Y. N., Cho, H., & Lee, L. P. (2023) · Biosensors · doi:10.3390/bios13020231 · Cited by 17
Lab-On-A-Chip for the Development of Pro-/Anti-Angiogenic Nanomedicines to Treat Brain Diseases
Parimalam, S. S., Bǎdilescu, S., Sonenberg, N., Bhat, R., & Packirisamy, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20246126 · Cited by 15
Metadata
- Authors
- Nguyen, D.-H. T., Lee, E., Alimperti, S., Norgard, R. J., Wong, A., Lee, J. J.-K., Eyckmans, J., Stanger, B. Z., & Chen, C. S.
- Affiliations
- University of Pennsylvania (US)
- Boston University (US)
- Harvard University (US)
- Corresponding author
- Nguyen, Duc-Huy T.
- Lee, Esak
- Chen, Christopher S.
- ORCID
- Venue
- Science Advances
- Published
- 2019-08-02
- Volume
- 5
- Issue
- 8
- Pages
- eaav6789-eaav6789
- ISSN
- 2375-2548 (ISSN-L)
- PMC
- PMC6713506
- OpenAlex
- W2970097127
- Cited by
- 172
- References
- 40
- Citations by year
- 2026: 8 · 2025: 30 · 2024: 28 · 2023: 26 · 2022: 25 · 2021: 27 · 2020: 26 · 2019: 2
- FWCI
- 8.36
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc
- Locations
- Science Advances (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- OpenBU (Boston University) (submittedVersion, cc-by-nc)
- Funders
- National Institutes of Health (EB00262, UH3EB017103, UC4DK104196)
- National Center for Advancing Translational Sciences (TL1TR001410)
- Lymphatic Education and Research Network (LE&RN Postdoctoral Fellowship)
- Harvard Ludwig Center
- Topics
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Keywords
- pancreatic ductal adenocarcinoma, tumor vascular invasion, tumor angiogenesis
- MeSH terms
- Adenocarcinoma, Animals, Cell Line, Humans, Neoplasm Invasiveness, Pancreatic Neoplasms, Signal Transduction, Carcinoma, Pancreatic Ductal, Activin Receptors, Type I, Biomimetics, Endothelial Cells, Cell Line, Tumor, Mice, Human Umbilical Vein Endothelial Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.